Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells

Tissue Engineering - Part A

Volumn 16, Issue 12, 2010, Pages 3647-3655

  Payne, Karin A ^a,b   Meszaros, Laura B ^a,b,c   Phillippi, Julie A ^b   Huard, Johnny ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; BONE; CELL PROLIFERATION; ENZYME ACTIVITY; GENE EXPRESSION; MINERALOGY; MUSCLE; PHOSPHATASES; PIGMENTS; PROTEINS; SIGNALING; STEM CELLS; SUGARS;

ALKALINE PHOSPHATASE ACTIVITY; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE TISSUE ENGINEERING; CELL SOURCES; CELLULAR PROLIFERATIONS; EXTRACELLULAR SIGNAL-REGULATED KINASE; LY294002; MUSCLE-DERIVED STEM CELLS; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION; P38 MAPK; P38 MITOGEN-ACTIVATED PROTEIN KINASE; SIGNALING PATHWAYS; SKELETAL MUSCLE; SPECIFIC INHIBITORS; STEM CELL; THERAPEUTIC TARGETS;

TISSUE ENGINEERING;

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BONE MORPHOGENETIC PROTEIN 4; CHROMONE DERIVATIVE; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; BONE DEVELOPMENT; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOUSE; MUSCLE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; FLAVONOIDS; IMIDAZOLES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; MUSCLE CELLS; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 78650049943     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0738     Document Type: Article

References (55)

1. Weissman, I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100, 157, 2000.
2. Gharaibeh, B., Lu, A., Tebbets, J., Zheng, B., Feduska, J., Crisan, M., et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 3, 1501, 2008.
3. Qu-Petersen, Z., Deasy, B., Jankowski, R., Ikezawa, M., Cummins, J., Pruchnic, R., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157, 851, 2002.
4. Cao, B., Zheng, B., Jankowski, R.J., Kimura, S., Ikezawa, M., Deasy, B., et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 5, 640, 2003.
5. Corsi, K.A., Schwarz, E.M., Mooney, D.J., and Huard, J. Regenerative medicine in orthopaedic surgery. J Orthop Res 25, 1261, 2007.
6. Kuroda, R., Usas, A., Kubo, S., Corsi, K., Peng, H., Rose, T., et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 54, 433, 2006.
7. Lee, J.Y., Qu-Petersen, Z., Cao, B., Kimura, S., Jankowski, R., Cummins, J., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150, 1085, 2000.
8. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
9. Wright, V., Peng, H., Usas, A., Young, B., Gearhart, B., Cummins, J., et al. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 6, 169, 2002.
10. Heldin, C.H., Miyazono, K., and ten Dijke, P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465, 1997.
11. Kretzschmar, M., and Massague, J. SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev 8, 103, 1998.
12. Massague, J. TGF-beta signal transduction. Annu Rev Bio-chem 67, 753, 1998.
13. Dang, Z.C., and Lowik, C.W. Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis. J Cell Biochem 92, 525, 2004.
14. Gallea, S., Lallemand, F., Atfi, A., Rawadi, G., Ramez, V., Spinella-Jaegle, S., et al. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28, 491, 2001.
15. Ghosh-Choudhury, N., Abboud, S.L., Nishimura, R., Celeste, A., Mahimainathan, L., and Choudhury, G.G. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277, 33361, 2002.
16. Nohe, A., Keating, E., Knaus, P., and Petersen, N.O. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16, 291, 2004.
17. Osyczka, A.M., and Leboy, P.S. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146, 3428, 2005.
18. Shoba, L.N., and Lee, J.C. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells. J Cell Biochem 88, 1247, 2003.
19. Simmons, C.A., Matlis, S., Thornton, A.J., Chen, S., Wang, C.Y., and Mooney, D.J. Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech 36, 1087, 2003.
20. Billings, P.C., Fiori, J.L., Bentwood, J.L., O'Connell, M.P., Jiao, X., Nussbaum, B., et al. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res 23, 305, 2008.
21. Seib, F.P., Franke, M., Jing, D., Werner, C., and Bornhauser, M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol 88, 257, 2009.
22. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270, 27489, 1995.
23. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364, 229, 1995.
24. Vlahos, C.J., Matter, W.F., Hui, K.Y., and Brown, R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J Biol Chem 269, 5241, 1994.
25. Lai, C.F., and Cheng, S.L. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem 277, 15514, 2002.
26. Noth, U., Tuli, R., Seghatoleslami, R., Howard, M., Shah, A., Hall, D.J., et al. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291, 201, 2003.
27. Guicheux, J., Lemonnier, J., Ghayor, C., Suzuki, A., Palmer, G., and Caverzasio, J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18, 2060, 2003.
28. Yuan, Y., Wu, Z.J., Yao, H.Y., Yu, X.D., Guo, Z.K., Chen, X.S., et al. Activation of p38 mitogen-activated protein kinase contribute to BMP4-induced alkaline phosphatase expression in MC3T3-E1 preosteoblast. Chin Med J (Engl) 119, 324, 2006.
29. Vinals, F., Lopez-Rovira, T., Rosa, J.L., and Ventura, F. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS Lett 510, 99, 2002.
30. Fujita, T., Azuma, Y., Fukuyama, R., Hattori, Y., Yoshida, C., Koida, M., et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166, 85, 2004.
31. Fujita, T., Fukuyama, R., Enomoto, H., and Komori, T. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2. J Cell Biochem 93, 374, 2004.
32. Hidaka, K., Kanematsu, T., Takeuchi, H., Nakata, M., Kikkawa, U., and Hirata, M. Involvement of the phosphoi-nositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5. Int J Biochem Cell Biol 33, 1094, 2001.
33. Kaliman, P., Vinals, F., Testar, X., Palacin, M., and Zorzano, A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271, 19146, 1996.
34. Sakaue, H., Ogawa, W., Matsumoto, M., Kuroda, S., Takata, M., Sugimoto, T., et al. Posttranscriptional control of adipo-cyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 273, 28945, 1998.
35. Canalis, E., Economides, A.N., and Gazzerro, E. Bone mor-phogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24, 218, 2003.
36. Kozawa, O., Hatakeyama, D., and Uematsu, T. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts. J Cell Biochem 84, 583, 2002.
37. Kozawa, O., Matsuno, H., and Uematsu, T. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone mor-phogenetic protein-4 in osteoblasts. J Cell Biochem 81, 430, 2001.
38. Tazoe, M., Mogi, M., Goto, S., and Togari, A. Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells. Arch Oral Biol 48, 615, 2003.
39. Jadlowiec, J., Koch, H., Zhang, X., Campbell, P.G., Seyedain, M., and Sfeir, C. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J Biol Chem 279, 53323, 2004.
40. Corsi, K.A., Pollett, J.B., Phillippi, J.A., Usas, A., Li, G., and Huard, J. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res 22, 1592, 2007.
41. Datta, S.R., Brunet, A., and Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev 13, 2905, 1999.
42. Song, G., Ouyang, G., and Bao, S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9, 59, 2005.
43. Hartel, F.V., Holl, M., Arshad, M., Aslam, M., Gunduz, D., Weyand, M., et al. Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells. Am J Physiol Cell Physiol 298, C1501, 2010.
44. Ambrosino, C., and Nebreda, A.R. Cell cycle regulation by p38 MAP kinases. Biol Cell 93, 47, 2001.
45. Wu, Z., Woodring, P.J., Bhakta, K.S., Tamura, K., Wen, F., Feramisco, J.R., et al. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20, 3951, 2000.
46. Engel, F.B., Schebesta, M., Duong, M.T., Lu, G., Ren, S., Madwed, J.B., et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19, 1175, 2005.
47. Elia, D., Madhala, D., Ardon, E., Reshef, R., and Halevy, O. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 1773, 1438, 2007.
48. Lund, A.W., Stegemann, J.P., and Plopper, G.E. Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three dimensional, collagen I culture. Stem Cells Dev 18, 331, 2008.
49. Kono, S.J., Oshima, Y., Hoshi, K., Bonewald, L.F., Oda, H., Nakamura, K., et al. Erk pathways negatively regulate matrix mineralization. Bone 40, 68, 2007.
50. Hu, Y., Chan, E., Wang, S.X., and Li, B. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144, 2068, 2003.
51. Celil, A.B., Hollinger, J.O., and Campbell, P.G. Osx tran-scriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95, 518, 2005.
52. Wang, X., Goh, C.H., and Li, B. p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology 148, 1629, 2007.
53. Collett, G.D., Sage, A.P., Kirton, J.P., Alexander, M.Y., Gil-more, A.P., and Canfield, A.E. Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. Circ Res 100, 502, 2007.
54. Davies, S.P., Reddy, H., Caivano, M., and Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95, 2000.
55. Kretzschmar, M., Doody, J., and Massague, J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389, 618, 1997.